Neogenomics Intrinsic Stock Value – Needham: Limited Impact of NeoGenomics Ruling on Estimates
🌧️Trending News NEOGENOMICS ($NASDAQ:NEO): Needham recently released a statement noting that they believe the recent ruling on NeoGenomics will have [...]
NEOGENOMICS Reports 18% Increase in Third Quarter Earnings for FY2023 with Total Revenue of USD 151.9 Million
☀️Earnings Overview NEOGENOMICS ($NASDAQ:NEO) reported total revenue of USD 151.9 million for its third quarter of FY2023, which was an [...]
NEOGENOMICS Reports Fiscal Year 2023 Third Quarter Earnings on November 6, 2023
🌥️Earnings Overview On November 6, 2023, NEOGENOMICS ($NASDAQ:NEO) released its earnings report for the fiscal year 2023 third quarter, which [...]
Neogenomics Intrinsic Value Calculator – NeoGenomics Posts $19M Net Loss in Q3 Despite Fort Myers Base
🌧️Trending News NEOGENOMICS ($NASDAQ:NEO): Despite being headquartered in Fort Myers, NeoGenomics recently reported a net loss of $19 million for [...]
Neogenomics Reports Anticipation for Q2 Earnings Call Amidst Financial Challenges
☀️Introduction: Investors and financial enthusiasts are eagerly awaiting Neogenomics Corporation's upcoming earnings call, scheduled for August 8, 2023, at 8:30 [...]
Neogenomics Intrinsic Value – NEOGENOMICS Reports Record Q2 Earnings for FY2023
🌥️Earnings Overview On August 8 2023, NEOGENOMICS ($NASDAQ:NEO) released their earnings results for the second quarter of FY2023 ending June [...]
NEOGENOMICS Reports 17.5% Year-Over-Year Increase in FY 2023 Second Quarter Revenue of $146.9 Million
☀️Earnings Overview For the Fiscal Year 2023 Second Quarter ending June 30 2023, NEOGENOMICS ($NASDAQ:NEO) reported a total revenue of [...]
Neogenomics Intrinsic Stock Value – Eleven Ratings Firms Agree: NeoGenomics Shares Earn ‘Moderate Buy’ Recommendation
☀️Trending News NEOGENOMICS ($NASDAQ:NEO): NeoGenomics, Inc. is a leading provider of cancer-focused genetic testing and pharmaceutical services. The company, which [...]
Brown Advisory Increases Stake in NeoGenomics,
🌥️Trending News NEOGENOMICS ($NASDAQ:NEO): NeoGenomics, Inc. is a leading provider of cancer-focused genetic testing and information services. The company has [...]
Neogenomics Intrinsic Value – Analysts Agree: ‘Moderate Buy’ Rating Given to NeoGenomics, Shares
☀️Trending News NEOGENOMICS ($NASDAQ:NEO): NeoGenomics, Inc. is a leading provider of cancer-focused genetic testing services and solutions. They specialize in [...]
